| Novartis Pharma Schweiz AG - Atectura Breezhaler 150/320 μg, Hartkapseln mit Pulver zur Inhalation |
| 67597 | | 03 | | Atectura Breezhaler 150/320 μg | | Hartkapseln mit Pulver zur Inhalation | | R03AK14 | | Indacaterol and Mometasone | | 10.09.2020 | | |
|
| Composition |
| indacaterolum 0.150 mg ut indacateroli acetas, mometasoni-17 furoas 0.320 mg, lactosum monohydricum, Kapselhülle: gelatina, pro capsula. |
| Packungsbestandteile |
| Inhalation Powder | | | | | Active Agent | Dose |
|---|
| Indacaterolum | 0.15 mg |
| | BAG: Active Agent | Dose |
|---|
| Indacaterolum | 0.15 mg | | Mometasone 17 Furoate | 0.32 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Gelatina | | Kapselhülle | | Lactose Monohydrate | | | | Mometasone 17 Furoate | 0.32 mg | | | Pro Capsula | | |
| |
|
|
